Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Non-cash Items (2021 - 2025)

Lucid Diagnostics' Non-cash Items history spans 5 years, with the latest figure at $396000.0 for Q4 2025.

  • For Q4 2025, Non-cash Items rose 98.99% year-over-year to $396000.0; the TTM value through Dec 2025 reached $396000.0, up 98.99%, while the annual FY2025 figure was $396000.0, 98.99% up from the prior year.
  • Non-cash Items reached $396000.0 in Q4 2025 per LUCD's latest filing, up from $307000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $2.0 million in Q1 2025 to a low of $499.0 in Q3 2022.
  • Average Non-cash Items over 5 years is $407856.0, with a median of $307000.0 recorded in 2025.
  • Peak YoY movement for Non-cash Items: surged 69439.08% in 2023, then plummeted 73.99% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $6665.0 in 2021, then skyrocketed by 6321.61% to $428000.0 in 2022, then skyrocketed by 78.74% to $765000.0 in 2023, then tumbled by 73.99% to $199000.0 in 2024, then soared by 98.99% to $396000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Non-cash Items are $396000.0 (Q4 2025), $307000.0 (Q3 2025), and $446000.0 (Q2 2025).